On Sept. 8, the Centers for Disease Control and Prevention (CDC) released “HIV and Sexually Transmitted Infections Among Persons with Monkeypox—Eight U.S. Jurisdictions, May 17 – July 22, 2022” in its Morbidity and Mortality Weekly Report (MMWR). Data in this report show people with HIV and other sexually transmitted infections (STIs) are disproportionately affected by monkeypox. The findings highlight a critical opportunity to use established HIV and STI care and prevention delivery systems for monkeypox prevention efforts. Click here to learn more.
On Aug. 25, The New England Journal of Medicine published “Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022,” which highlights the potential for atypical clinical presentations of monkeypox that are not included in typical case definitions. The authors recommend consideration of monkeypox in at-risk persons presenting with traditional STI symptoms. Click here to learn more.
- Monkeypox Vaccine Performance Data and Vaccine Expansion Eligibility
- Update on Monkeypox – A New FYI Video (HIV.gov)
- CDC: Clinical Considerations for Treatment and Prophylaxis of Monkeypox Virus Infection in People with HIV
- Monkeypox: Georgia Department of Public Health
- Signs and Symptoms (per CDC)
- What You Need to Know (APIC)
- CDC’s Response